Lv11
20 积分 2023-12-18 加入
F41 The proof-hd phase 3 study: pridopidine’s outcome on function in huntington disease (PROOF)
2小时前
求助中
F41 The proof-hd phase 3 study: pridopidine’s outcome on function in huntington disease (PROOF)
4小时前
求助中
Design, Biological Characterization, and Discovery of Novel Cyclohexenyl Derivatives as Kinesin KIF18A Inhibitors for the Treatment of Ovarian Cancer
10天前
已完结
Levels and Interactions of p27, Cyclin D3, and CDK4 During the Formation and Maintenance of the Corpus Luteum in Mice1
5个月前
已完结
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor
5个月前
已完结
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor
9个月前
已完结
Abstract 2568: ARTS-021 is a potent and selective CDK2 inhibitor that demonstrates anti-cancer activity in preclinical cancer models with CCNE1 amplification
10个月前
已完结
Synthesis and biological evaluation of novel pteridin-7(8H)-one derivatives as potent CDK2 inhibitors
11个月前
已完结
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer
11个月前
已完结
皖公网安备34019202002308
